DiaMedica Therapeutics Inc. SC 13G and SC 13G/A reports

Location
301 Carlson Parkway, Suite 210, Minneapolis, Minnesota
State of incorporation
Canada (Federal Level)
Fiscal year end
December 31
Data updated at
6/27/2024, 01:24 AM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report SC 13G/A Jun 27, 2023
SC 13G/A Report SC 13G/A Jun 27, 2023
SC 13G/A Report SC 13G/A Jun 23, 2023
SC 13G/A Report Feb 13, 2023
SC 13G/A Report SC 13G/A Jan 13, 2023
SC 13G/A Report SCHEDULE 13G Dec 6, 2022
SC 13G/A Report SCHEDULE 13G Jul 12, 2022
SC 13G Report SC 13G May 27, 2022
SC 13G/A Report Feb 15, 2022
SC 13G/A Report Feb 11, 2022
SC 13G Report SCHEDULE 13G Oct 8, 2021
SC 13G Report SCHEDULE 13G Oct 8, 2021
SC 13G Report Oct 6, 2021
SC 13G/A Report Feb 12, 2021
SC 13G/A Report SCHEDULE 13G/A Dec 23, 2020
SC 13G Report Feb 12, 2020
SC 13G/A Report AMENDMENT TO FORM SC 13G Jan 31, 2020
SC 13G Report SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP Apr 29, 2019
SC 13G Report SCHEDULE 13G Feb 1, 2019
SC 13G Report SCHEDULE 13G Jan 29, 2019
SC 13G Report SCHEDULE 13G Jan 24, 2019